[HTML][HTML] Migraine: from pathophysiology to treatment
F Puledda, EM Silva, K Suwanlaong, PJ Goadsby - Journal of Neurology, 2023 - Springer
Migraine is an extremely disabling, common neurological disorder characterized by a
complex neurobiology, involving a series of central and peripheral nervous system areas …
complex neurobiology, involving a series of central and peripheral nervous system areas …
[HTML][HTML] Applying a biopsychosocial model to migraine: rationale and clinical implications
C Rosignoli, R Ornello, A Onofri, V Caponnetto… - The journal of headache …, 2022 - Springer
Migraine is a complex condition in which genetic predisposition interacts with other
biological and environmental factors determining its course. A hyperresponsive brain cortex …
biological and environmental factors determining its course. A hyperresponsive brain cortex …
Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial
Background In this study, we aimed to evaluate the efficacy, safety, and tolerability of
atogepant for the preventive treatment of chronic migraine. Methods We did this randomised …
atogepant for the preventive treatment of chronic migraine. Methods We did this randomised …
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: a systematic review and network meta-analysis of phase 3 randomised …
Background Several novel treatments targeting the calcitonin gene-related peptide pathway
have been developed for migraine. We evaluated the efficacy of these medications …
have been developed for migraine. We evaluated the efficacy of these medications …
[HTML][HTML] Exploring novel therapeutic targets in the common pathogenic factors in migraine and neuropathic pain
J Tajti, D Szok, A Csáti, Á Szabó, M Tanaka… - International Journal of …, 2023 - mdpi.com
Migraine and neuropathic pain (NP) are both painful, disabling, chronic conditions which
exhibit some symptom similarities and are thus considered to share a common etiology. The …
exhibit some symptom similarities and are thus considered to share a common etiology. The …
[HTML][HTML] Debate: differences and similarities between tension-type headache and migraine
Tension-type headache (TTH) and migraine are two common primary headaches
distinguished by clinical characteristics according to the 3rd edition of the International …
distinguished by clinical characteristics according to the 3rd edition of the International …
Idiopathic intracranial hypertension: a step change in understanding the disease mechanisms
The understanding of idiopathic intracranial hypertension (IIH) has evolved over the past few
years. Previously, IIH was considered a disease exclusively affecting the neuro-ophthalmic …
years. Previously, IIH was considered a disease exclusively affecting the neuro-ophthalmic …
[HTML][HTML] Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study
Background Clinical trials have shown that erenumab is effective and well-tolerated for the
preventive treatment of chronic migraine. To extend the results from clinical trials, we …
preventive treatment of chronic migraine. To extend the results from clinical trials, we …
[HTML][HTML] The effect of Lu AG09222 on PACAP38-and VIP-induced vasodilation, heart rate increase, and headache in healthy subjects: An interventional, randomized …
NB Rasmussen, C Deligianni, CE Christensen… - The Journal of …, 2023 - Springer
Background Pituitary adenylate cyclase-activating polypeptide (PACAP), structurally related
to vasoactive intestinal peptide (VIP), is one of the important mediators in the pathogenesis …
to vasoactive intestinal peptide (VIP), is one of the important mediators in the pathogenesis …
[HTML][HTML] The sense of stopping migraine prophylaxis
Introduction Migraine prophylactic therapy has changed over recent years with the
development and approval of monoclonal antibodies (mAbs) targeting the calcitonin gene …
development and approval of monoclonal antibodies (mAbs) targeting the calcitonin gene …